Neratinib and Trastuzumab Biosimilar in Patients with HER2 Mutated Advanced Solid Cancers
Clinical trial NCT06083662 · COMPLETED
Trial details
- NCT number
- NCT06083662
- Sponsor
- Korea University Guro Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-15
- Primary completion
- 2023-11-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.